REMORGIDA V

No description

No description

No description

IntroductionAs far back as 2000, Possover et al. reported a mixed vagi-nal and laparoscopic route in colorectal resection for deependometriosis, aiming at a better preservation of bladderand rectal nerves [1]. The number of scientific articlesreporting series of patients managed for deep endometriosisworldwide has progressively increased for...

OBJECTIVE: To assess the efficacy of surgical excision of endometriosis in treating pain symptoms caused by moderate/severe endometriosis (ASRM stage III/IV) in depressed patients (group D) and in non-depressed controls (group N). DESIGN: Comparative assessor-blinded prospective study. MATERIALS AND METHODS: The study included women of...

OBJECTIVE: To compare the efficacy of norethisterone acetate (NETA, group N) or NETA and letrozole (group L) in treating endometriotic ovarian cysts. DESIGN: This patient preference study was performed between February 2010 and November 2011 in the University hospital of Genoa, Italy. MATERIALS AND METHODS: Patients with single non-recurrent...

Study Objective: The primary outcome of the study was to assess the usefulness of intraoperative transvaginal ultrasonography (iTVS) during multiple laparoscopic myomectomy (LM) in identifying and removing uterine fibroids. The secondary aim of the study was to assess the value of iTVS in evaluating the quality of the suture performed to close...

No description

No description

To evaluate selective salpingography sensitivity.

OBJECTIVE: To assess the efficacy of norethindrone acetate (NETA) for the treatment of pain symptoms caused by rectovaginal endometri- osis in depressed patients (group D) and in non-depressed controls (group N). DESIGN: Open-label assessor-blinded prospective comparative study. MATERIALS AND METHODS: Patients were treated with NETA (2.5...

STUDY QUESTION: Does the presence of aggregates of smooth endoplasmic reticulum (SERa) impact the transcriptome of human metaphase II (MII) oocytes?. SUMMARY ANSWER: The presence of SERa alters the molecular status of human metaphase II oocytes. WHAT IS KNOWN ALREADY: Oocytes presenting SERa are considered dysmorphic. Oocytes with SERa (SERa+)...

No description